Companies like Oracle (ORCL), Microsoft (MSFT) as well as riskier investments in quantum computing and AI are crowding out the interest in slower moving stocks like Procter and Gamble.

Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges with supply chain costs.

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ORCL: Procter & Gamble NewsMORE Related Stocks Indices Commodities Currencies Stocks

Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat corporate earnings sent stocks to fresh highs. Tech stocks dominated the list of biggest gainers after President Trump unveiled The Stargate Project,

Wells Fargo raised the firm’s price target on Procter & Gamble to $180 from $176 and keeps an Overweight rating on the shares. The bias on

Shares of household products giant Procter & Gamble (NYSE: PG) were gaining today after the maker of Crest toothpaste and Gillette razors posted another solid earnings report, edging out analyst ...

Oracle (NYSE:ORCL) stock jumped 8.7% higher ... in an up to $500 billion private-sector investment into artificial intelligence infrastructure. Procter & Gamble (NYSE:PG) stock rose 3.3% after the consumer goods giant reported net sales in its fiscal ...

(Reuters) -Procter & Gamble beat second-quarter results estimates on Wednesday, driven by growing demand for its household items such as Pantene shampoos and Tide detergents as product innovations acr

nbsp; Procter & Gamble (PG)announced second quarter fiscal ... up to $500 billion investment deal with SoftBank (SFTBY) and Oracle (ORCL), despite backing from his allies — including President ...

and Procter & Gamble (PG). In the artificial intelligence (AI) realm, President Donald Trump announced "Stargate," a massive joint venture with OpenAI, Oracle (ORCL), and Softbank on AI ...

Sign up for the Marketplace newsletter to get the day’s biggest business stories, our economic analysis, and explainers to help you live smarter, straight to your ...

Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total Income ...